Renal Cancer - Results from #3020

Renal Function Impairment Below Safety Limits Correlates With Cancer-specific Mortality in Localized Renal Cell Carcinoma: Results From a Single-center Study. January 28, 2020

Prognostic value of downregulated 5-hydroxymethylcytosine expression in renal cell carcinoma: a 10 year follow-up retrospective study. January 28, 2020

Survival benefit with extended lymphadenectomy for advanced renal malignancy: A population-based analysis. January 28, 2020

Interleukin-2 chronotherapy for metastatic renal cell carcinoma: Results of a phase I-II study. January 27, 2020

Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group. January 27, 2020

MiR-22 functions as a biomarker and regulates cell proliferation, cycle, apoptosis, migration and invasion in renal cell carcinoma. January 27, 2020

The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor. January 24, 2020

Deep learning to distinguish benign from malignant renal lesions based on routine MR imaging. January 24, 2020

MiR-935 Promotes Clear Cell Renal Cell Carcinoma Migration and Invasion by Targeting IREB2. January 24, 2020

Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma. January 23, 2020

HOXC11 functions as a novel oncogene in human colon adenocarcinoma and kidney renal clear cell carcinoma. January 23, 2020

MiR-765 functions as a tumour suppressor and eliminates lipids in clear cell renal cell carcinoma by downregulating PLP2. January 23, 2020

Split Renal Function in Patients with Renal Masses: Utility of Parenchymal Volume Analysis versus Nuclear Renal Scans. January 23, 2020

Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma. January 23, 2020

Development and validation of an immune prognostic classifier for clear cell renal cell carcinoma. January 22, 2020

A historical turning point for the treatment of advanced renal cell carcinoma: ınhibition of ımmune checkpoint. January 22, 2020

Characterisation of renal cell carcinoma-associated constitutional chromosome abnormalities by genome sequencing. January 22, 2020

Computed Tomography Imaging Characteristics of Histologically Confirmed Papillary Renal Cell Carcinoma-Implications for Ancillary Imaging. January 21, 2020

Renal Neuroendocrine Neoplasms: A Single-center Experience. January 21, 2020

Establishment of cohesion 1 homolog 2 facilitates cell aggressive behaviors and induces poor prognosis in renal cell carcinoma. January 21, 2020

Page 152 of 456